ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups

November 6, 1998

ASCO Recommends End of Life Discussions

January 28, 2011

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

In Brief: Rosenberg To Give Karnofsky Lecture at ASCO, Minna To Present Rosenthal Lecture At AACR

April 27, 1984

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

May 25, 2001

NCAB Opposes Line Item for Centers

May 23, 1980